Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | 20% Disc. US CNS Disorders Drug Pipeline Insight 2014Bharatbook.com announces a 20% discount on a report "US CNS Disorders Drug Pipeline Insight 2014". This report highlight market overview & incidence by disease, CNS disorder pipeline by disease, phase & company.(Discount Valid till 31st DEC. 2014)
By: Bharat Book Bureau The Central Nervous System (CNS) disorders market in US is one of the largest segments of pharmaceuticals industry. The numbers of CNS disorders have increased at an alarming rate, while the available therapies were unable to meet the market requirements. There has been steady to rapid growth in the market for CNS disorder, especially over the past two decades. The market for CNS therapies is one of the largest therapeutic categories and also one of the fastest growing. US account for more than 55% of the global CNS Disorders drugs market. Within the CNS market, the biggest therapeutic area is the market for anti-psychotics, followed by anti-depressive and mood stab markets. Anti-epileptic and anti-Alzheimer’ New technology including advancements in stem cell therapy and of nanotechnology is expected to drive the growth of the CNS market. Nanotechnology in the form of the nano-materials for wound care, drug delivery and immunomodulation is specifically seen as a positive influence on CNS therapy that is expected to open growth opportunities. While each of these therapeutic subcategories are served by established treatments there are certain markets segments with significant unmet medical needs still remain, indicating potential in these areas. There are newer treatment methodologies under development such as that using stem cell therapy and of nanotechnology that seek to address these opportunities. “US CNS Disorders Drug Pipeline Insight 2014” Report Highlight: • Market Overview & Incidence by Disease • CNS Disorder Market Dynamics • CNS Disorder Pipeline by disease, Phase & Company • CNS Disorder Pipeline: 1083 Drugs in Pipeline • Majority CNS Drugs in Preclinical Phase: 396 Drugs • Majority CNS Drugs for Neurodegenerative Disorders: 228 Drugs in Pipeline • CNS Disorder Market Drugs: 109 Drugs • Majority CNS Drugs Marketed for Epilepsy: 24 Drugs Table of Contents 1. Introduction to Central Nervous System (CNS) Disorder 2. US Central Nervous System (CNS) Disorder Market Overview 2.1 Market Overview 2.2 Clinical Pipeline Insight 3. US Central Nervous System (CNS) Disorder Incidence by Disease 3.1 Alzheimer's Disease 3.2 Multiple Sclerosis 4. US Central Nervous System (CNS) Disorder Market Dynamics 4.1 Favorable Market Parameters 4.2 Market Challenges 5. US Multiple CNS Disorder Drug Pipeline by Phase & Company 5.1 Clinical Pipeline Insight by Phase & Company 5.2 Marketed Drugs Clinical Profile For more information kindly visit :https://www.bharatbook.com/ Discounted Reports: https://www.bharatbook.com/ About Bharat Book Bureau: Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry analysis , country reports , business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology. In case the reports don’t match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself. OR Contact us at : Bharat Book Bureau Tel: +91 22 27810772 / 27810773 Toll Free No for USA/Canada : 1-866-279-8368 Email: info@bharatbook.com Website: www.bharatbook.com Follow us on twitter: https:// End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|